Exanthema caused by ingestion of potassium p-aminobenzoate (POTABA-Glenwood®)
Corresponding Author
Ulf Meyer-Hoffert
Department of Dermatology, Allergology and Venerology, University Hospitals of Schleswig-Holstein Campus, 24105 Kiel, Germany
Ulf Meyer-Hoffert, Department of Dermatology, University Hospitals of Schleswig-Holstein, Campus Kiel, Schittenhelmstraße 7, 24105 Kiel, Germany. Tel: +49 431 597 1602; Fax: +49 431 597 1611. E-mail: [email protected]Search for more papers by this authorJens-Michael Jensen
Department of Dermatology, Allergology and Venerology, University Hospitals of Schleswig-Holstein Campus, 24105 Kiel, Germany
Search for more papers by this authorJochen Brasch
Department of Dermatology, Allergology and Venerology, University Hospitals of Schleswig-Holstein Campus, 24105 Kiel, Germany
Search for more papers by this authorCorresponding Author
Ulf Meyer-Hoffert
Department of Dermatology, Allergology and Venerology, University Hospitals of Schleswig-Holstein Campus, 24105 Kiel, Germany
Ulf Meyer-Hoffert, Department of Dermatology, University Hospitals of Schleswig-Holstein, Campus Kiel, Schittenhelmstraße 7, 24105 Kiel, Germany. Tel: +49 431 597 1602; Fax: +49 431 597 1611. E-mail: [email protected]Search for more papers by this authorJens-Michael Jensen
Department of Dermatology, Allergology and Venerology, University Hospitals of Schleswig-Holstein Campus, 24105 Kiel, Germany
Search for more papers by this authorJochen Brasch
Department of Dermatology, Allergology and Venerology, University Hospitals of Schleswig-Holstein Campus, 24105 Kiel, Germany
Search for more papers by this authorConflicts of interest: The authors have declared no conflicts.
References
- 1 Schnuch A, Aberer W, Agathos M, Brasch J, Frosch P J, Fuchs T, Richter G. Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) zur Durchführung des Epikutantests mit Kontaktallergenen Hautarzt 2001: 52: 864–866.
- 2 Zarafonetis C J D, Horrax T M. Treatment of Peyronie's disease with potassium para-aminobenzoate (Potaba) J Urol 1959: 81: 770–772.
- 3 Hauck E W, Bschleipfer T, Haag S M, Rohde V, Weidner W. Assessment among German urologists of various conservative treatment modalities for Peyronie's disease: results of a survey Urologe A 2005: 44: 1189–1196.
- 4 Roy J, Carrier S. Acute hepatitis associated with treatment of Peyronie's disease with potassium para-aminobenzoate (Potaba) J Sex Med 2008: 5: 2967–2969.
- 5 Stoevesandt J, Kürzinger N, Bröcker E B, Trautmann A. Uro-dermatological problems of a construction worker: paraaminobenzoic acid as a systemic photosensitizer Eur J Dermatol 2010: 20: 217–219.
- 6 Gasparro F P, Mitchnick M, Nash J F. A review of sunscreen safety and efficacy Photochem Photobiol 1998: 68: 243–256.
- 7 Uter W, Lessmann H, Geier J, Becker D, Fuchs T, Richter G, IVDK Study Group. German Contact Dermatitis Research Group (DKG): the spectrum of allergic (cross-)sensitivity in clinical patch testing with ‘para amino’ compounds Allergy 2002: 57: 319–322.
- 8 Mayer R L. Experimental sensitisation with food dyes and cross-sensitisation to paraphenylenediamine J Allergy 1949: 20: 159–166.
- 9 Kardaun S H, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici B B, Mockenhaupt M, Roujeau J C. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007: 156: 609–610.
Citing Literature
